Effects of three oral dosage of S 44121 on cardiac arrhythmia during exercise testing in patients with catecholaminergic polymorphic ventricular tachycardia type 1. A 3-days, single-blind, international multicentre study. - ND
- Conditions
- Catecholaminergic polymorphic vetricular tachycardia (CPVT) type 1.MedDRA version: 9.1Level: LLTClassification code 10036095
- Registration Number
- EUCTR2009-011560-11-IT
- Lead Sponsor
- INSTITUT DE RECHERCHES INTERNATIONALES SERVIER
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 16
Inclusion Criteria
Male or female, age superior or equal to 18 years - Established diagnosis of CPVT type1 - Treatment with beta-blocker - Qualifying ETs meeting a predefined degree of severity and stability of the disease.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Resting ECG with an abnormality that could preclude a proper interpretation of the ECG obtained during the ETs. - Chronic heart failure. - Structural congenital heart disease.
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method